🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-31
Trial ID
NCT01678677
Treatments Being Tested
This is a phase 1, single centre trial in Japanese healthy male subjects co...
Status
Completed
Location
Investigational site
Start Date
2018-03-20
Trial ID
NCT03476746
Treatments Being Tested
This study will assess up to 12 different oral formulations of apremilast t...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2014-01-07
Trial ID
NCT02236988
Treatments Being Tested
Polycystic ovary syndrome (PCOS) is a common endocrine disorder frequently ...
Status
Not Yet Recruiting
Location
Dicle University Hospital
Start Date
2026-08-20
Trial ID
NCT07770711
Treatments Being Tested
Chlorhexidine is considered as gold standard for its antiplaque and antigin...
Status
Completed
Location
GCD Indore
Start Date
2017-04-12
Trial ID
NCT03474146
Treatments Being Tested
The purpose of this study is to investigate the effects of EPA- and DHA-enr...
Status
Completed
Location
Northumbria University
Start Date
2017-08-01
Trial ID
NCT03592251
Treatments Being Tested
This phase II trial tests how well radiation therapy with pembrolizumab and...
Status
Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2025-10-22
Trial ID
NCT06492759
A multicenter, randomized, double-blind, vehicle-controlled, parallel group...
Status
Completed
Location
Beijing Children's Hospital, Capital Medical University
Start Date
2023-02-17
Trial ID
NCT05650320
Treatments Being Tested
This phase III trial compares the effect of adding stereotactic body radiat...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-07-12
Trial ID
NCT05624996
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-22
Trial ID
NCT01659086
Treatments Being Tested